Inspection and Audit Findings Related to Artwork and Packaging Inspection and Audit Findings Related to Artwork and Packaging In the regulated pharmaceutical industry, regulatory affairs (RA) professionals play a crucial role in ensuring that product labeling, artwork, and packaging comply with the governing regulations and guidelines. This document provides an in-depth examination of the frameworks guiding pharmaceutical labeling compliance in the US, EU, and UK regions, along with inspection and audit findings typically observed by regulatory bodies. Context Pharmaceutical labeling encompasses all information appearing on product labels, packaging materials, and accompanying literature, including package inserts and user instructions. Regulatory affairs…

Aligning Artwork Timelines with Regulatory and Supply Milestones Aligning Artwork Timelines with Regulatory and Supply Milestones The pharmaceutical landscape is increasingly characterized by the need for compliance with various global regulations, especially related to labelling and packaging. This article serves as a comprehensive guide for Regulatory Affairs (RA) professionals, CMC and Labelling teams in the US, UK, and EU, detailing the essential aspects of pharmaceutical labelling compliance concerning artwork processes, proofing, Braille, and packaging regulations. Regulatory Affairs Context In the realm of pharmaceutical development and commercialization, Regulatory Affairs plays a crucial role in ensuring that the artwork and packaging of…

Case Studies: Packaging Errors and How They Were Prevented—or Not Case Studies: Packaging Errors and How They Were Prevented—or Not Context In the pharmaceutical industry, regulatory compliance concerning packaging and labelling is paramount. Errors in packaging can lead to serious consequences, including patient harm, regulatory sanctions, and significant financial penalties. This article explores common packaging-related errors, their regulatory implications, and how these issues can be prevented through robust pharmaceutical labelling compliance and effective product information governance. Legal/Regulatory Basis The regulatory framework for packaging and labelling in the pharmaceutical industry is established by various guidelines and regulations across different jurisdictions. Key…

Integrating Braille and Accessibility Considerations into Standard Workflows Integrating Braille and Accessibility Considerations into Standard Workflows Context In the pharmaceutical industry, compliance with labelling requirements is crucial for ensuring patient safety and promoting ethical practices. As part of these requirements, incorporating accessibility features such as Braille on packaging is increasingly mandated, facilitating proper use of medical products by individuals with visual impairments. Understanding how to effectively integrate Braille into the existing standard workflows is essential for regulatory affairs (RA) professionals, especially in the context of regulatory expectations set forth by agencies such as the FDA, EMA, and MHRA. Legal/Regulatory Basis…

Barcodes, 2D Codes and Serialisation: What RA Needs to Check Barcodes, 2D Codes and Serialisation: What RA Needs to Check In the rapidly evolving field of pharmaceuticals, regulatory affairs professionals play a crucial role in ensuring compliance with labelling standards, particularly regarding the use of barcodes, 2D codes, and serialization. This article provides a comprehensive overview of the relevant regulations, guidelines, and agency expectations pertinent to these aspects, drawing on the regulatory frameworks in the US, UK, and EU. Regulatory Affairs Context The pharmaceutical industry faces stringent regulations to ensure that products are safely and effectively delivered to consumers. Regulatory…

Vendor Qualification and Monitoring for Printing and Packaging Partners Vendor Qualification and Monitoring for Printing and Packaging Partners In the complex landscape of pharmaceutical and biotech product development, the role of effective vendor qualification and monitoring for printing and packaging partners cannot be overstated. This is critical in ensuring that products are compliant with regulatory standards across various jurisdictions, specifically concerning pharmaceutical labelling compliance, product information governance, and global artwork and packaging control. This article aims to provide a comprehensive regulatory explainer regarding these processes within the context of pharmacovigilance systems, aligning with the expectations of regulatory agencies such as…

Running Effective Artwork Review Meetings Across Functions Running Effective Artwork Review Meetings Across Functions Context The regulatory landscape for pharmaceutical labelling and artwork compliance is intricate and requires collaboration across various functions within an organization. Effective artwork review meetings are crucial for ensuring adherence to regulatory requirements while maintaining product safety and efficacy. This article serves as a comprehensive guide to the artwork review process, addressing regulatory guidelines, documentation requirements, and common pitfalls encountered by regulatory affairs (RA) professionals. Legal/Regulatory Basis In the US, the Food and Drug Administration (FDA) regulates pharmaceutical labeling under 21 CFR Part 201. In the…

KPIs That Show Whether Artwork Processes Are Under Control KPIs That Show Whether Artwork Processes Are Under Control In the highly regulated pharmaceutical industry, ensuring that artwork processes meet compliance standards is essential for product acceptance and success in the market. Regulatory Affairs professionals, especially those involved in labelling and packaging compliance, must focus on key performance indicators (KPIs) that reflect the efficiency and effectiveness of these processes. This article serves as a comprehensive guide to understanding the KPIs related to artwork processes, aligned with the expectations of global regulatory authorities such as the FDA, EMA, and MHRA. Regulatory Context…

Crisis Management When Artwork Errors Reach the Market Crisis Management When Artwork Errors Reach the Market Context In the highly regulated pharmaceutical landscape, errors in product artwork and information can have significant implications for compliance, patient safety, and corporate reputation. Regulatory Affairs (RA) professionals are tasked with ensuring that product labels, packaging, and patient information meet all applicable legal and regulatory requirements. As pharmaceutical companies navigate the complexities of product information governance, effective crisis management strategies become essential for addressing artwork errors that inadvertently reach the market. Legal/Regulatory Basis Both the US and the EU have stringent regulations governing product…

Future Trends: eLabelling, Smart Packaging and Digital Artwork Review Future Trends: eLabelling, Smart Packaging and Digital Artwork Review Context As pharmaceuticals evolve to meet modern healthcare demands, regulatory affairs professionals play a crucial role in ensuring compliance with multiple regulatory frameworks. The rise of eLabeling, smart packaging, and digital artwork review represents a significant shift toward more dynamic and efficient product information governance. This article aims to elucidate the regulatory landscape surrounding these trends, focusing on the expectations of key regulatory agencies in the US, EU, and UK. Legal/Regulatory Basis Understanding the legal and regulatory basis for eLabelling, smart packaging,…